Next generation of Trojan-horse drugs designed to minimize damage to healthy cells
Funding for the act, which aims to speed approval of new drugs and devices, may be in jeopardy
U.S. trade agency requires products say there is no scientific evidence for effectiveness
Enhancing the body's own immune system is leading to promising results in the battle against malignancy
The result could be a major setback for the strategy of attacking amyloid plaques
A low-fiber diet causes fiber-eating microbes to dwindle, opening up real estate for mucus munchers that make the intestine more vulnerable to infection. Christopher Intagliata reports.
National Institutes of Health Director Francis Collins talks about the future of the NIH in light of the election.
A strain that emerged during the latest epidemic is able to enter human cells more easily—which means it’s more infectious, too. Christopher Intagliata reports.
Priorities at the NIH, the BRAIN Initiative, drug price controls and more initiatives could shift in major ways
The new president-elect will have to consider how to drive down health costs
Voters sent some strong signals on marijuana use and assisted suicide
The employee noticed a tear in protective clothing, and has been offered an experimental vaccine
These Truths Are Not Self-Evident—but They've Been Firmly Established Over and Over by Scientific Research
A compendium of irrefutable facts for these fact-starved times
The drug-resistant fungus is often fatal and can be difficult to identify
A brain plaque inhibitor developed by Merck is now being tested in larger studies for efficacy against the still unstoppable neurodegenerative disease
Metformin may slow or reverse dementia and cognitive impairment, even in nondiabetics
In precision medicine era legacy gifts of patient brain tissue reveal disease mechanisms and new therapeutic approaches
New findings underscore the challenge of balancing psychiatric needs and potential negative consequences for newborns
After decades of disappointment there is a new flurry of vaccine activity
Scientists have already started testing the treatment in humans